Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Core Scientific (CORZ) Preferred Stock Liabilities (2020 - 2021)

Core Scientific has reported Preferred Stock Liabilities over the past 2 years, most recently at $44.5 million for Q4 2021.

Quarterly results put Preferred Stock Liabilities at $44.5 million for Q4 2021, changed 0.0% from a year ago — trailing twelve months through Dec 2021 was $44.5 million (changed 0.0% YoY), and the annual figure for FY2021 was $44.5 million, changed 0.0%.
Preferred Stock Liabilities reached $44.5 million in Q4 2021 per CORZ's latest filing, down from $345.0 million in the prior quarter.
Across five years, Preferred Stock Liabilities topped out at $345.0 million in Q3 2021 and bottomed at $44.5 million in Q4 2020.